v1
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer.
Identifier:nobleid.org/w1/20260515/C2ABB96D
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/C2ABB96D)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims